4.5 Review

Alterations in platelets during SARS-CoV-2 infection

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Anwarul Hasan et al.

Summary: This review discusses the interactions between the novel coronavirus SARS-CoV-2 and human cells, highlighting the role of important receptors like ACE-2 and furin in the virus invasion. It explores the potential inhibitory effects of compounds on the virus, as well as future prospects for drug development.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Anesthesiology

Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019

Jonathan H. Chow et al.

Summary: A retrospective cohort study in multiple hospitals in the United States showed that aspirin use in COVID-19 patients may be associated with reduced risk of mechanical ventilation, ICU admission, and in-hospital mortality. Further studies are needed to confirm a causal relationship.

ANESTHESIA AND ANALGESIA (2021)

Review Critical Care Medicine

Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza A Systematic Review

Lida P. Hariri et al.

Summary: The histopathologic pattern of COVID-19, H1N1 influenza, and SARS patients predominantly involves acute-phase diffuse alveolar damage (DAD), with more frequent pulmonary microthrombi observed in COVID-19 and SARS patients compared to H1N1 influenza. Further research is needed to validate these findings and explore their clinical implications.

CHEST (2021)

Article Cardiac & Cardiovascular Systems

Immature platelets in patients hospitalized with Covid-19

Amir Cohen et al.

Summary: The study found that Covid-19 patients have significantly increased immature platelet indices, which further intensify as the disease progresses, possibly contributing to the development of thrombotic events.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Review Cell Biology

The Impact of COVID-19 Disease on Platelets and Coagulation

Geoffrey D. Wool et al.

Summary: COVID-19 infection can lead to a proinflammatory state and abnormalities in the coagulation mechanism, with patients often experiencing thrombosis. Elevated levels of D-dimer are positively correlated with mortality, and patients typically exhibit mild thrombocytopenia.

PATHOBIOLOGY (2021)

Article Hematology

Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report

Axel Rosell et al.

Summary: The study found that COVID-19 patients have significantly higher levels of circulating EV TF activity compared to healthy controls. This increased activity was associated with disease severity, mortality, and markers like D-dimer, indicating a potential role of EV TF in driving thrombosis in COVID-19 patients.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Article Hematology

Antibody-induced procoagulant platelets in severe COVID-19 infection

Karina Althaus et al.

Summary: The pathophysiology of COVID-19-associated thrombosis is multifactorial, involving procoagulant platelets and alterations in various cellular processes. Studies have found that COVID-19 patients exhibit increased platelet dysfunction and apoptosis markers, suggesting a potential role of antibody-mediated procoagulant platelets in contributing to sustained thromboembolic risk in ICU COVID-19 patients.

BLOOD (2021)

Review Medicine, General & Internal

COVID-19 coagulopathy: is it disseminated intravascular coagulation?

Marcel Levi et al.

Summary: Severe COVID-19 infections can lead to coagulopathy related to both venous and arterial thromboembolic disease, with characteristics that are similar but not identical to DIC. The virus's direct infection and damage to endothelial cells affect the coagulation response to COVID-19, potentially requiring separate diagnostic criteria for this distinct intravascular coagulation syndrome.

INTERNAL AND EMERGENCY MEDICINE (2021)

Article Immunology

Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019

Eleonora Petito et al.

Summary: Patients with COVID-19 exhibit high levels of platelet and neutrophil activation, particularly in severe cases, which are associated with thrombosis. NET biomarkers may aid in predicting disease progression and VTE risk, and may guide the use of low-molecular-weight heparin treatment.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor

Jarrod Shilts et al.

Summary: Recent studies suggest that basigin may not be the receptor for SARS-CoV-2 virus to invade human cells, and removing basigin from the surface of human lung epithelial cells does not affect susceptibility to the virus. These findings provide more information for a better understanding and treatment of COVID-19.

SCIENTIFIC REPORTS (2021)

Article Cell Biology

Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection

Giuseppe Cappellano et al.

Summary: This study evaluated the diagnostic performance of circulating platelets-derived extracellular vesicles as biomarkers for Sars-Cov-2 infection, suggesting that PLT-EVs might be an interesting biomarker deserving further investigations to test their predictive power.

CELLS (2021)

Article Critical Care Medicine

Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes Systematic Review and Meta-analysis

Edison J. Cano et al.

Summary: A systematic review of literature on corticosteroids and COVID-19 found evidence of mortality benefit in severely ill COVID-19 patients treated with corticosteroids. However, there were no significant differences in outcomes between high-dose and low-dose corticosteroid regimens. Low-dose corticosteroids do not appear to significantly impact the duration of SARS-CoV-2 viral shedding based on emerging evidence. Further high-quality clinical trials are needed to determine the most beneficial timing and dosing for corticosteroids in the rapidly evolving global pandemic.

CHEST (2021)

Review Critical Care Medicine

Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019 A Systematic Review and Meta-analysis

David Jimenez et al.

Summary: The pooled incidence of VTE and bleeding among hospitalized patients with COVID-19 was 17.0% and 7.8% respectively. Factors such as routine screening, critical illness, inclusion of distal DVT and subsegmental PE, and prospective studies were associated with higher rates of VTE. The incidence of bleeding events was sensitive to escalated doses of anticoagulants and the nature of data collection.

CHEST (2021)

Article Hematology

Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia

Ishac Nazy et al.

Summary: Our study excludes heparin-induced thrombocytopenia in critically ill COVID-19 patients and identifies platelet-activating immune complexes as a novel mechanism contributing to the disease.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Medicine, General & Internal

Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19

Qiang Liu et al.

Summary: In a study involving adults infected with SARS-Cov-2, it was found that patients using low-dose aspirin (100 mg/day) had significantly lower 30-day and 60-day mortality rates compared to those not using aspirin, although there was no significant difference in viral duration between the two groups.

MEDICINE (2021)

Review Cell Biology

Platelets and viruses

Silvio Antoniak et al.

Summary: Platelets play a crucial role in maintaining vascular integrity after injury and contribute to the immune response to pathogens. During viral infections, they can both reduce blood-borne viruses by engulfing them and enhance inflammation and tissue injury.

PLATELETS (2021)

Article Biochemistry & Molecular Biology

COVID-19 induces a hyperactive phenotype in circulating platelets

Shane P. Comer et al.

Summary: This study found distinct differences in routine full blood count and other clinical laboratory parameters between patients with severe and nonsevere COVID-19. It also determined that all COVID-19 patients possess hyperactive circulating platelets, suggesting abnormal platelet reactivity may contribute to hypercoagulability in COVID-19, influencing the severity of the disease and recovery path complexity.

PLOS BIOLOGY (2021)

Article Hematology

Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19

Carolin Langnau et al.

Summary: Patients with CAD and SARS-CoV-2 infection exhibit elevated systemic platelet activation and enhanced plasma levels of the subtilisin-like proprotein convertase furin, which may contribute to an unfavorable clinical prognosis.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Review Infectious Diseases

Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality

M. Flook et al.

Summary: In the study of COVID-19, age, gender, and comorbidities are common risk factors assessed. Despite most studies focusing on risk factors, only age has solid evidence support. More mechanistic studies are needed to understand why age is such an important risk factor.

BMC INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

The spatial landscape of lung pathology during COVID-19 progression

Andre F. Rendeiro et al.

Summary: Recent studies using high-parameter imaging mass cytometry have provided insights into the cellular composition and spatial architecture of acute lung injury in humans, including injuries derived from SARS-CoV-2 infection. It was found that SARS-CoV-2 predominantly infects alveolar epithelial cells and induces a localized hyperinflammatory cell state associated with lung damage. As COVID-19 progresses, there is increased macrophage extravasation, along with increased numbers of mesenchymal cells and fibroblasts, possibly indicating attempts to repair the damaged lung tissue. The data generated help in developing a biologically interpretable landscape of lung pathology at both macroscopic and single-cell levels, providing a basis for understanding COVID-19 and lung pathology.

NATURE (2021)

Article Medicine, General & Internal

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

Robert Flisiak et al.

Summary: The study demonstrated the significant impact of tocilizumab on reducing mortality and accelerating clinical improvement in COVID-19 patients with a baseline concentration of IL-6 > 100 pg/mL, particularly those who require oxygen supplementation.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Pathology

A Descriptive and Quantitative Immunohistochemical Study Demonstrating a Spectrum of Platelet Recruitment Patterns Across Pulmonary Infections Including COVID-19

Phillip D. McMullen et al.

Summary: The study compared the level of platelet deposition in cases of confirmed COVID-19 infection to other lung injuries and infections, finding that the area of CD61 staining in COVID-19 infection was higher than influenza but still comparable to many other infectious diseases. Aspiration pneumonia, Staphylococcus aureus infection, and blastomycosis exhibited the highest levels of CD61 staining.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients

Paola Canzano et al.

Summary: The authors suggest that the cytokine storm in COVID-19 patients can lead to sustained cell-based activation of coagulation and altered platelet activity, which can be intervened through prophylactic anticoagulant treatment.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Hematology

Mechanism of thrombocytopenia in COVID-19 patients

Panyang Xu et al.

ANNALS OF HEMATOLOGY (2020)

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

Article Medicine, General & Internal

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

Li-Li Ren et al.

CHINESE MEDICAL JOURNAL (2020)

Review Biochemistry & Molecular Biology

Cytokine storm intervention in the early stages of COVID-19 pneumonia

Xinjuan Sun et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Editorial Material Cardiac & Cardiovascular Systems

Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Gian Battista Danzi et al.

EUROPEAN HEART JOURNAL (2020)

Editorial Material Critical Care Medicine

Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19

Berangere S. Joly et al.

INTENSIVE CARE MEDICINE (2020)

Editorial Material Cell Biology

Platelets get gutted by PAG

Ivan Parra-Izquierdo et al.

PLATELETS (2020)

Editorial Material Multidisciplinary Sciences

Cytokine release syndrome in severe COVID-19

John B. Moore et al.

SCIENCE (2020)

Article Hematology

Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia

Songping Cui et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Letter Hematology

Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19

Marisa Dolhnikoff et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Surgery

The need to manage the risk of thromboembolism in COVID-19 patients

Inayat Hussain Khan et al.

JOURNAL OF VASCULAR SURGERY (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Biochemistry & Molecular Biology

CD147 is a Novel Interaction Partner of Integrin αMβ2 Mediating Leukocyte and Platelet Adhesion

David Heinzmann et al.

BIOMOLECULES (2020)

Letter Cardiac & Cardiovascular Systems

Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease

Tessa J. Barrett et al.

CIRCULATION RESEARCH (2020)

Article Medical Laboratory Technology

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Giuseppe Lippi et al.

CLINICA CHIMICA ACTA (2020)

Review Hematology

Megakaryocyte and Platelet Transcriptomics for Discoveries in Human Health and Disease

Pavel Davizon-Castillo et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Article Hematology

Platelet gene expression and function in patients with COVID-19

Bhanu Kanth Manne et al.

BLOOD (2020)

Article Medicine, Research & Experimental

Neutrophil extracelluar traps in COVID-19

Yu Zuo et al.

JCI INSIGHT (2020)

Article Cardiac & Cardiovascular Systems

Association of Microvesicles With Graft Patency in Patients Undergoing CABG Surgery

Marina Camera et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19

Younes Zaid et al.

CIRCULATION RESEARCH (2020)

Article Multidisciplinary Sciences

Clinical characteristics of 82 cases of death from COVID-19

Bicheng Zhang et al.

PLOS ONE (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Oncology

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

Si Zhang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Article Hematology

COVID-19 patients exhibit reduced procoagulant platelet responses

Frederik Denorme et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies

Alessandro Di Minno et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)

Article Biochemistry & Molecular Biology

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Ke Wang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Editorial Material Cardiac & Cardiovascular Systems

Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Gian Battista Danzi et al.

EUROPEAN HEART JOURNAL (2020)

Article Biochemistry & Molecular Biology

Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia

Sivasami Pulavendran et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)

Article Critical Care Medicine

Effects of antiplatelet therapy on the mortality rate of patients with sepsis: A meta-analysis

Yaqi Ouyang et al.

JOURNAL OF CRITICAL CARE (2019)

Article Multidisciplinary Sciences

The role of platelets in mediating a response to human influenza infection

Milka Koupenova et al.

NATURE COMMUNICATIONS (2019)

Review Immunology

Platelets in Inflammation and Resolution

Andreas Margraf et al.

JOURNAL OF IMMUNOLOGY (2019)

Article Infectious Diseases

Dengue viruses infect human megakaryocytes, with probable clinical consequences

Megan B. Vogt et al.

PLOS NEGLECTED TROPICAL DISEASES (2019)

Article Infectious Diseases

Clinical and Laboratory Findings of Middle East Respiratory Syndrome Coronavirus Infection

Se-Min Hwang et al.

JAPANESE JOURNAL OF INFECTIOUS DISEASES (2019)

Article Infectious Diseases

Antiviral activity of aspirin against RNA viruses of the respiratory tract-an in vitro study

Bernadette Glatthaar-Saalmueller et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2017)

Article Immunology

TLR7/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA

Christian Lood et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Review Peripheral Vascular Disease

Effects of Aspirin on Endothelial Function and Hypertension

Mikhail S. Dzeshka et al.

CURRENT HYPERTENSION REPORTS (2016)

Article Medical Laboratory Technology

Correlation Between Abnormal Platelet Count and Respiratory Viral Infection in Patients From Cheonan, Korea

Jae Kyung Kim et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2016)

Article Cardiac & Cardiovascular Systems

Lower Mortality Rate in Elderly Patients With Community-Onset Pneumonia on Treatment With Aspirin

Marco Falcone et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)

Review Neurosciences

Platelets: a critical link between inflammation and microvascular dysfunction

Karen Y. Stokes et al.

JOURNAL OF PHYSIOLOGY-LONDON (2012)

Article Immunology

Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans

Thea Morris et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Hematology

Crosstalk between coagulation and inflammation during Dengue virus infection

Alejandra Huerta-Zepeda et al.

THROMBOSIS AND HAEMOSTASIS (2008)

Article Medicine, General & Internal

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis

RSM Wong et al.

BRITISH MEDICAL JOURNAL (2003)

Article Multidisciplinary Sciences

CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A

T Pushkarsky et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Medicine, General & Internal

Blood coagulation

B Dahlback

LANCET (2000)